Página 55 - v24n1

17. Shapiro J. Topical immunotherapy in the treatment of chronic
severe alopecia areata. Dermatol Clin 1993; 11: 611-7.
18. Alkhalifah A, Alsantali A, Wang E, McElwee KJ, Shapiro J.Alopecia
areata update: part II. Treatment. J Am Acad Dermatol 2010; 62:
191-202.
19. Macdonald Hull S, Cunliffe WJ. Successful treatment of alopecia
areata using the contact allergen diphencyprone. Br J Dermatol
1991; 124: 212-3.
20. Galán-Gutiérrez M, Rodríguez-Bujaldón A, Moreno-Giménez JC.
Actualización terapéutica en alopecia areata. Actas Dermosifi-
liogr 2009; 100: 266-76.
21. McDonald N, Wiseman MC, Shapiro J. Alopecia areata: topical
immunotherapy. Application and practical problems. J Cut Med
Surg 1999; 3: 36-41.
22. Buckley DA, Du Viver AWP. The therapeutic use of topical contact
sensitizers in bening dermatoses. Br J Dermatol 2001; 145:
285-405.
23. Tosti A, Guidetti MS, Bardazzi F et al. Long-term results of topical
immunotherapy in children with alopecia totalis or alopecia uni-
versalis. J Am Acad Dermatol 1996; 35: 199-201.
24. Rokhsar CK, Shupack JL, Vafai JJ, Washenik K. Efficacy of topical
sensitizers in the treatment of alopecia areata. J Am Acad Der-
matol1998; 39: 751-61.
25. Singh G, Lavanya MS. Topical immunotherapy in alopecia areata.
Int J Trichol 2010; 2: 36-9.
26. Nelson DA, Spielvogel RL. Anthralin therapy for alopecia areata.
Int J Dermatol 1985; 24: 606-7.
27. Sasmaz S, Arican O. Comparison of azelaic acid and anthralin for
the therapy of patchy alopecia areata: a pilot study. Am J Clin
Dermatol 2005; 6: 403-6.
28. García-Bravo B, Rodríguez-Pichardo A, Sánchez Pedreño P,
Camacho F. Nickel sulphato in treatment of alopecia areata. Con-
tact Dermatitis1989; 20: 228-9.
Monografías de Dermatología 52